Skip to main content
Caplight Logo









EmbodyX

EmbodyX

Private
Oakland, CaliforniaFrontier & Industrial Techhttps://embodyx.io

Last Round

Seed

Feb 1, 2026

Momentum

Top 5%

of companies Caplight tracks

Company Overview

EmbodyX operates in Frontier & Industrial Tech and is based in Oakland, California. Its latest recorded funding round was a Seed round in February 2026.

EmbodyX is a robotics and artificial intelligence company that develops physical AI models and software to enable robots and edge devices to operate autonomously in dynamic environments.

Sector

Frontier & Industrial Tech

Verticals

Industrial Robotics, Warehouse Automation, Smart Manufacturing, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EmbodyX Comparables

Compare EmbodyX with similar companies based on industry and business-model similarity.

EmbodyX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Skild AI
83%
Sereact
83%
Rhoda AI
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EmbodyX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 1, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

EmbodyX Investors

Notable investors and investment history

EmbodyX investors
InvestorRounds
Id4 VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 2, 2026

    Open roles increased to 12, 3.1x the trailing average.

  • Oct 12, 2026

    Open roles increased to 5, representing 45% of headcount.

Book a demo to see all signals

For institutional investors. Book with your work email.

EmbodyX Filings

Explore SEC and related filing metadata, where available.

EmbodyX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EmbodyX's valuation, stock price, and market status.

Is EmbodyX a public or private company?

EmbodyX is a private company.

What is the current stock price of EmbodyX?

EmbodyX is a private company, so its shares have no public market price. Caplight tracks EmbodyX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EmbodyX worth (valuation)?

Valuation information for EmbodyX is not publicly available.

Can I buy EmbodyX stock?

EmbodyX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EmbodyX's last funding round?

EmbodyX's most recent funding round was Seed on February 1, 2026.

Who are the main investors in EmbodyX?

Key investors in EmbodyX include Id4 Ventures.

Will EmbodyX IPO soon?

No public IPO plans have been announced for EmbodyX.

How can I track EmbodyX secondary market activity?

Caplight tracks bids, offers, and trades in EmbodyX's shares on secondary markets.

Firmographic Details

HeadquartersOakland, California
Employee Range7
Year Founded2025
Last FundingFeb 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?